Resolve BioSciences Funding: $100M Raised, Series B (2022)
Resolve BioSciences is based in Monheim am Rhein, Germany. It has raised $100M in total funding. Latest round: Series B.
Resolve BioSciences funding overview
Resolve BioSciences is based in Monheim am Rhein, Germany. Resolve BioSciences has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2022. The round record for Resolve BioSciences runs through 2022; nothing later has been disclosed. Investors on record include Patient Square Capital, EDBI, PS Capital, Alafi Capital, NRW.BANK. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Resolve BioSciences funding
How much has Resolve BioSciences raised?
Resolve BioSciences has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Resolve BioSciences?
Patient Square Capital, EDBI, PS Capital, Alafi Capital, NRW.BANK are named among the investors backing Resolve BioSciences.
What was the latest Resolve BioSciences funding round?
The most recent disclosed round is a Series B, announced in October 2022.
Where is Resolve BioSciences based?
Resolve BioSciences is based in Monheim am Rhein, Germany.
When did Resolve BioSciences last raise?
The last disclosed Resolve BioSciences round closed in October 2022 at Series B.
We update the Resolve BioSciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Monheim am Rhein and their backers are listed below.
